Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

Investors Count

1

Deal Terms

1

Galena Biopharma - Zuplenz Funding, Galena Biopharma - Zuplenz Valuation & Galena Biopharma - Zuplenz Revenue

1 Fundings

Galena Biopharma - Zuplenz's latest funding round was a Acquired Unit for on December 18, 2015.

Galena Biopharma - Zuplenz's latest post-money valuation is from December 2015.

Sign up for a free 30-day trial to see Galena Biopharma - Zuplenz's valuations in December 2015 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/18/2015

Acquired Unit

$99M

$0.00B

((9.99x))

FY 1234

1

Date

12/18/2015

Round

Acquired Unit

Amount

Investors

Valuation

$99M

Revenue

$0.00B

((9.99x))

FY 1234

Sources

1

Galena Biopharma - Zuplenz Deal Terms

1 Deal Term

Galena Biopharma - Zuplenz's deal structure is available for 1 funding round, including their Acquired Unit from December 18, 2015.

Round

Acquired Unit

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired Unit

Galena Biopharma - Zuplenz Investors

1 Investors

Galena Biopharma - Zuplenz has 1 investors. Midatech Pharma invested in Galena Biopharma - Zuplenz's Acquired Unit funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/18/2015

12/18/2015

1
Acquired Unit

Corporation

United Kingdom

First funding

12/18/2015

Last Funding

12/18/2015

Investor

Rounds

1
Acquired Unit

Board Seats

Type

Corporation

Location

United Kingdom

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.